An Observer-blind, Cohort Randomized, Exploratory Phase 3 Study to Evaluate the Safety and Immunogenicity of Recombinant Covid-19 Vaccine, mRNA Covid-19 Vaccine and Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine as 4th Dose in Individuals Primed/ Boosted With Various Regimens
Clinical trial NCT05470803 · UNKNOWN
Trial details
- NCT number
- NCT05470803
- Sponsor
- D'Or Institute for Research and Education
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2022-12-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.